Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
duration of venetoclax aml | 1.12 | 0.4 | 4541 | 65 | 26 |
duration | 0.16 | 0.6 | 674 | 85 | 8 |
of | 0.75 | 0.1 | 9216 | 85 | 2 |
venetoclax | 1.31 | 1 | 7424 | 99 | 10 |
aml | 1.77 | 0.8 | 5261 | 76 | 3 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
duration of venetoclax aml | 1.35 | 0.7 | 5960 | 83 |
venetoclax aml 14 days | 1.82 | 0.3 | 5870 | 42 |
venetoclax aml phase 1 | 0.75 | 0.9 | 3862 | 25 |
venetoclax success rate aml | 1.55 | 0.7 | 9602 | 23 |
venetoclax mechanism of action aml | 0.29 | 0.9 | 2455 | 54 |
venetoclax indication in aml | 0.44 | 0.7 | 5733 | 20 |
venetoclax in relapsed aml | 0.31 | 0.4 | 1177 | 36 |
venetoclax resistance in aml | 1.22 | 0.2 | 3401 | 99 |
venetoclax package insert aml | 0.03 | 0.3 | 5640 | 87 |
venetoclax and vidaza for aml | 1.27 | 0.3 | 2080 | 68 |
venetoclax fda approval aml | 0.75 | 1 | 5699 | 57 |
vidaza venetoclax aml regimen | 0.07 | 0.3 | 4014 | 36 |
venetoclax ramp up aml | 0.14 | 0.1 | 3310 | 12 |
venetoclax azacitidine aml protocol | 1.28 | 0.2 | 2626 | 80 |
venetoclax azacitidine relapsed aml | 1.02 | 0.8 | 3190 | 11 |
venetoclax azacitidine aml protocol pdf | 1.36 | 1 | 6783 | 11 |
venclexta dosage for aml | 0.45 | 0.1 | 581 | 54 |
venetoclax acute myeloid leukemia | 1.23 | 0.3 | 9808 | 5 |
how long can you take venetoclax | 1.46 | 0.5 | 1460 | 14 |